TPW 196
Alternative Names: TPW-196Latest Information Update: 07 Mar 2016
Price :
$50 *
At a glance
- Originator Teikoku Pharma USA
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 07 Mar 2016 Discontinued - Phase-I for Pain in USA (Transdermal)
- 18 Dec 2014 Phase-I clinical trials in Pain in USA (Transdermal)